Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology
Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology ultrasound scanner (SCAN10/24/90).
Siemens would have had international rights to market thescanner once it was developed. Interspec retains worldwide rightsto the technology developed cooperatively. The smaller firm plansto sell the system itself through a combination of direct salesand distribution agreements, according to Edward Ray, chairmanand CEO.
"Interspec will take advantage of this opportunity andexpand its established international distribution to market itsnew product when it becomes available," Ray said.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.